Tumor-induced angiogenesis as an essential prerequisite for tumor growth, and consequently anti-angiogenesis as a treatment modality, was first proposed by Folkman5 and became feasible after identification of the endothelial-selective growth factor vascular endothelial growth factor A (VEGF-A)6,7. This evidence concerns the gene VEGFA and neoplasm.